RECOVER: Researching COVID to Enhance Recovery (2024)

Table of Contents

RECOVER Research Review (R3) Seminar Series Upcoming Seminars Previous Seminars Mechanistic Pathways of PASC Session 1: Overview of Mechanistic Pathways Vascular Pathophysiology of PASC Understanding the Biomarkers of PASC Frequency and Burden of Symptoms Following SARS-CoV-2 Infection Leveraging Mobile Health Platform Technologies to Understand PASC SARS-CoV-2 Infection: Findings from Autopsy Studies Clinical Spectrum of PASC: Focus on Coagulopathies Clinical Spectrum of PASC: Focus on Sleep Clinical Spectrum of PASC: Focus on Mental Health Clinical Spectrum of PASC: Sex Differences in PASC Clinical Spectrum of PASC: Focus on Metabolism and Gastrointestinal Function Clinical Spectrum of PASC: Focus on Cardio-Pulmonary Function Clinical Spectrum of PASC: Focus on Neuro-cognitive Function Leveraging EHR/Real World Data to Understand PASC Clinical Spectrum of PASC: Focus on Dysautonomia Clinical Spectrum of PASC: Focus on Pediatrics, including MIS-C Commonalities with Other Disorders and Post-viral Syndromes: Focus on ME/CFS Clinical Spectrum of PASC: Overview Epidemiology of Post-Acute Sequelae of SARS-CoV-2 Infection: Current Understanding and Key Questions FAQs References

RECOVER Research Review (R3) Seminar Series

The goal of the R3 Seminar Series is to promote a shared understanding of the scientific research on Long COVID for the RECOVER Consortium. This forum accelerates discovery by allowing experts to share their latest insights on Long COVID and related conditions. Some R3 sessions are also designed to inform the public about RECOVER and other research on Long COVID. All sessions are recorded and posted to recoverCOVID.org.

Upcoming Seminars

March 14, 2023

(Previously scheduled for February 28, 2023)

RECOVER in Action: Characterization of PASC Among Adults, EHR Insights

Source: NIH

Check back for upcoming seminars!

Previous Seminars

Sort by

January 10, 2023 • Source: NIH
Mechanistic Pathways of PASC Session 1: Overview of Mechanistic Pathways
Akiko Iwasaki, PhD, Yale School of Medicine

Jim Stone, MD, PhD, Massachusetts General Hospital

Amy Proal, PhD, PolyBio Research Foundation

Marrah Lachowicz-Scroggins, PhD, National Institutes of Health, National Heart, Lung, and Blood Institute (NHLBI)
Watch Recording
Audio transcript (PDF, 247 KB)
December 13, 2022 • Source: NIH
Vascular Pathophysiology of PASC
Joel Trinity, PhD, University of Utah

Katelyn Ludwig, PhD, University of Colorado

Naomi Hamburg, MD, MS, Boston Medical Center

Discussant: Janet Mullington, PhD, Harvard Medical School; Beth Israel Deaconess Medical Center
See Also
RECOVER: Researching COVID to Enhance Recovery Researching COVID to enhance recovery (RECOVER) autopsy tissue pathology study protocol: Rationale, objectives, and design Postacute Sequelae of SARS-CoV-2 Infection Susan Morgello - Anatomic Pathology and Clinical Pathology | Mount Sinai - New York
Watch Recording
Audio transcript (PDF, 233 KB)
November 8, 2022 • Source: NIH
Understanding the Biomarkers of PASC
Michael Peluso, MD, University of California, San Francisco

Mohamed Abdel-Mohsen, PhD, The Wistar Institute

David R. Walt, PhD, Harvard Medical School; Brigham and Women's Hospital

Grace McComsey, MD, University Hospitals Health System; Case Western Reserve University
Watch Recording
Audio transcript (PDF, 236 KB)
Responses to participants' questions (PDF, 228 KB)
October 25, 2022 • Source: NIH
Frequency and Burden of Symptoms Following SARS-CoV-2 Infection
Nedra Whitehead, PhD, RTI International

Sarah Hughes, PhD, University of Birmingham

Sharon Saydah, PhD, MHS, Centers for Disease Control and Prevention

Leora Horwitz, MD, NYU Langone Health
Watch Recording
Audio transcript (PDF, 244 KB)
Responses to participants' questions (PDF, 257 KB)
October 11, 2022 • Source: NIH
Leveraging Mobile Health Platform Technologies to Understand PASC
Jennifer Radin, PhD, MPH, Scripps Research Translational Institute

Vik Kheterpal, MD, CareEvolution

Arjun Venkatesh, MD, MBA, MHS, Yale School of Medicine

Erica Spatz, MD, MHS, Yale School of Medicine

Andrew Weitz, PhD, National Institute of Biomedical Imaging and Bioengineering
Watch Recording
Audio transcript (PDF, 238 KB)
Responses to participants' questions (PDF, 234 KB)
September 27, 2022 • Source: NIH
SARS-CoV-2 Infection: Findings from Autopsy Studies
Stephanie Haasnoot, Icahn School of Medicine at Mount Sinai Hospital

Marie-Abele Bind, PhD, Massachusetts General Hospital

Lauren Decker, MD, New Mexico Office of the Medical Investigator

James Stone, MD, PhD, Massachusetts General Hospital; Harvard Medical School
Watch Recording
Audio transcript (PDF, 230 KB)
Responses to participants' questions (PDF, 231 KB)
September 13, 2022 • Source: NIH
Clinical Spectrum of PASC: Focus on Coagulopathies
Jean Connors, MD, Brigham and Women's Hospital; Harvard Medical School

Resia Pretorius, PhD, Stellenbosch University

Jeffrey S. Berger, MD, MS, FAHA, FACC, NYU Langone School of Medicine

Shari Brosnahan, MD, NYU Langone School of Medicine
Watch Recording
Audio transcript (PDF, 233 KB)
Responses to participants' questions (PDF, 199 KB)
August 23, 2022 • Source: NIH
Clinical Spectrum of PASC: Focus on Sleep
Sairam Parthasarathy, MD, University of Arizona

Susan Redline, MD, MPH, Harvard Medical School; Harvard TH Chan School of Public Health; Brigham and Women's Hospital

Monika Haack, PhD, Harvard Medical School; Beth Israel Deaconess Medical Center

Janet Mullington, PhD, Harvard Medical School; Beth Israel Deaconess Medical Center
Watch Recording
Audio transcript (PDF, 224 KB)
Responses to participants' questions (PDF, 180 KB)
August 9, 2022 • Source: NIH
Clinical Spectrum of PASC: Focus on Mental Health
Richard Gallagher, PhD, NYU Langone Health

Roy Perlis, MD, MSc, Massachusetts General Hospital

Doug Bremner, MD, Emory University School of Medicine

Naomi Simon, MD, MSc, NYU Langone Health
Watch Recording
Audio transcript (PDF, 239 KB)
Responses to participants' questions (PDF, 308 KB)
July 26, 2022 • Source: NIH
Clinical Spectrum of PASC: Sex Differences in PASC
Andrea Edlow, MD, MSc, Massachusetts General Hospital; Harvard Medical School

Vanessa Jacoby, MD, MAS, University of California San Francisco

Jim Hotaling, MD, MS, FECSM, University of Utah

Torri Metz, MD, MS, University of Utah
Watch Recording
Audio transcript (PDF, 229 KB)
Responses to participants' questions (PDF, 220 KB)
July 12, 2022 • Source: NIH
Clinical Spectrum of PASC: Focus on Metabolism and Gastrointestinal Function
Clifford Rosen, MD, Tufts University School of Medicine; Maine Medical Center's Research Institute

Emily Gallagher, MD, PhD, Icahn School of Medicine at Mount Sinai

Jane Reusch, MD, University of Colorado Anschutz Medical Campus

Lucio Miele, MD, PhD, Louisiana State University Health Sciences Center

Philipp Scherer, PhD, Touchstone Diabetes Center; University of Texas Southwestern Medical Center
Watch Recording
Audio transcript (PDF, 233 KB)
Responses to participants' questions (PDF, 249 KB)
June 28, 2022 • Source: NIH
Clinical Spectrum of PASC: Focus on Cardio-Pulmonary Function
Jennifer Su, MD, Children's Hospital Los Angeles; University of Southern California

Aloke Finn, MD, CVPath Institute Inc; University of Maryland

Matt Oster, MD, MPH, Children's CORPS (Cardiac Outcomes Research Program at Sibley Heart Center); Children's Healthcare of Atlanta; Emory University

Anu Lala, MD, The Mount Sinai Hospital; Icahn School of Medicine at Mount Sinai

Erika Berman Rosenzweig, MD, Columbia University Medical Center/New York-Presbyterian Hospital
Watch Recording
Audio transcript (PDF, 238 KB)
Responses to participants' questions (PDF, 173 KB)
June 14, 2022 • Source: NIH
Clinical Spectrum of PASC: Focus on Neuro-cognitive Function
Melissa Cortez, DO, University of Utah Hospitals and Clinics

Alejandra González-Duarte, MD, PhD, NYU Langone Health

Sudha Seshadri, MD, University of Texas Health Sciences Center at San Antonio

Richard Gallagher, PhD, NYU Langone Health

Jennifer A. Frontera, MD, NYU Langone Health
Watch Recording
Audio transcript (PDF, 236 KB)
Responses to participants' questions (PDF, 203 KB)
May 24, 2022 • Source: NIH
Leveraging EHR/Real World Data to Understand PASC
Melissa Haendel, PhD, University of Colorado Anschutz Medical Campus

Thomas Carton, PhD, MS, Louisiana Public Health Institute

Christopher Chute, MD, DrPH, Johns Hopkins University

Rainu Kaushal, MD, MPH, Weill Cornell Medicine; New York-Presbyterian Hospital

Josh Fessel, MD, PhD, National Center for Advancing Translational Sciences, National Institutes of Health

Rachel Hess, MD, MS, Spencer Fox Eccles School of Medicine at the University of Utah
Watch Recording
Audio transcript (PDF, 223 KB)
Responses to participants' questions (PDF, 268 KB)
May 10, 2022 • Source: NIH
Clinical Spectrum of PASC: Focus on Dysautonomia
Mitchell Miglis, MD, Department of Neurology and Neurological Sciences, Stanford University

Tae Chung, MD, Johns Hopkins University

Lauren Stiles, JD, Dysautonomia International, Stony Brook University Renaissance School of Medicine

Satish Raj, MD MSCI, University of Calgary

Peter Novak, MD, PhD, Autonomic Laboratory, Brigham and Women's Faulkner Hospital, Harvard Medical School
Watch Recording
Audio transcript (PDF, 247 KB)
Responses to participants' questions (PDF, 228 KB)
April 26, 2022 • Source: NIH
Clinical Spectrum of PASC: Focus on Pediatrics, including MIS-C
Tellen D. Bennett, MD, MS, University of Colorado School of Medicine, Children’s Hospital Colorado

Gail D. Pearson, MD, ScD, Division of Cardiovascular Sciences at the National Heart, Lung, and Blood Institute, National Institutes of Health

Ravi Jhaveri, MD, FPIDS, FAAP, Ann & Robert H. Lurie Children’s Hospital of Chicago, Northwestern University Feinberg School of Medicine

Josh Fessel, MD, PhD, National Center for Advancing Translational Sciences, National Institutes of Health

Ericka L. Fink, MD, MS, UPMC Children's Hospital of Pittsburgh
Watch Recording
Audio transcript (PDF, 230 KB)
Responses to participants' questions (PDF, 271 KB)
April 12, 2022 • Source: NIH
Commonalities with Other Disorders and Post-viral Syndromes: Focus on ME/CFS
Nancy Klimas, MD, Director, Institute for Neuro-Immune Medicine, Nova Southeastern University, Miami VAMC GRECC

Anthony Komaroff, MD, Simcox-Clifford-Higby Professor of Medicine, Harvard Medical School, Senior Physician, Brigham and Women’s Hospital

Benjamin Natelson, MD, Director, Pain & Fatigue Study Center, Professor of Neurology, Icahn School of Medicine at Mount Sinai

David Systrom, MD, Assistant Professor of Medicine, Harvard Medical School, Brigham and Women’s Hospital
Watch Recording
Audio transcript (PDF, 225 KB)
Responses to participants' questions (PDF, 314 KB)
March 22, 2022 • Source: NIH
Clinical Spectrum of PASC: Overview
Hannah Davis, Co-Founder, Patient-Led Research Collaborative

Benard P. Dreyer, MD, FAAP, Professor of Pediatrics, NYU School of Medicine

Sindhu Mohandas, MD, Assistant Professor of Pediatrics, Infectious Diseases, Children’s Hospital Los Angeles, University of Southern California

Igho Ofotokun, MD, MSc, Professor of Medicine, Emory University
Watch Recording
Audio transcript (PDF, 186 KB)
Responses to participants' questions (PDF, 211 KB)
March 1, 2022 • Source: NIH
Epidemiology of Post-Acute Sequelae of SARS-CoV-2 Infection: Current Understanding and Key Questions
Sharon Saydah, PhD, Senior Scientist, Respiratory Viruses Branch, Division of Viral Diseases, Centers for Disease Control and Prevention

Elizabeth (Beth) Unger, MD, PhD, Chief, Chronic Viral Disease Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention

Steven G. Deeks, MD, Professor of Medicine in Residence, School of Medicine, University of California San Francisco; faculty, Division of HIV, Infectious Diseases and Global Medicine, Zuckerberg San Francisco General Hospital

Valerie Flaherman, MD, MPH, Professor of Pediatrics and Epidemiology and Biostatistics University of California, San Francisco
Watch Recording
Audio transcript (PDF, 179 KB)
Responses to participants' questions (PDF, 238 KB)

Find observational and tissue pathology studies near you at:
studies.recoverCOVID.org

RECOVER: Researching COVID to Enhance Recovery (2024)

FAQs

What can help recovery from Covid? ›

How to treat COVID-19 symptoms at home

get lots of rest.
drink plenty of fluids (water is best) to avoid dehydration – drink enough so your pee is light yellow and clear.
take paracetamol or ibuprofen if you feel uncomfortable.

Can you drink coffee with COVID? ›

Conclusions. The findings suggest that coffee can limit SARS-CoV-2 infection by inhibiting spike-ACE2 interactions, TMPRSS2, and CTSL. Coffee also reduced protein levels of ACE2 and TMPRSS2. Bioactive compounds in coffee, such as CGA, isoCGAs, and caffeine, showed inhibitory effects.

How long does COVID stay in your system? ›

Key Takeaways. How long COVID-19 stays in the body varies from person to person. Generally, people are no longer contagious about 10 days after symptoms first develop. COVID vaccination appears to significantly shorten infection times along with the length of time a person is contagious.

Which days of COVID are the worst? ›

Acute respiratory distress syndrome (ARDS) starts to be diagnosed, this is a respiratory problem when there is widespread inflammation in the lungs. Day 12: This is the median day to be admitted into the intensive care unit (ICU). Day 15: Acute kidney and cardiac injury becomes evident.

Show Me More ›

How to get rid of COVID fast? ›

Many people with COVID-19 get better with rest, fluids and treatment for their symptoms. Medicine you can get without a prescription can help. Some examples are: Fever reducers.

When should I test again after testing positive for COVID-19? ›

If your antigen test (such as an at-home test) result is positive, you may still be infectious. Continue wearing a mask and wait at least one day before taking another test.

Learn More ›

What vitamins to take if you test positive for COVID? ›

Although supplements do not reduce the risk of dying from COVID, vitamins C and D and zinc are essential nutrients that help support your immune system.2 This highly complex system defends your body from foreign invaders like bacteria and viruses.

Learn More ›

Are you still contagious after 5 days of COVID? ›

People with COVID-19 are often contagious for 5-10 days after their illness begins. People with flu may be contagious for up to 5-7 days after their illness begins. People with RSV are usually contagious for 3-8 days after their illness begins.

Get More Info ›

What not to eat when you have COVID? ›

Avoid foods (e.g. snacks) that are high in salt and sugar. Limit your intake of soft drinks or sodas and other drinks that are high in sugar (e.g. fruit juices, fruit juice concentrates and syrups, flavoured milks and yogurt drinks). Choose fresh fruits instead of sweet snacks such as cookies, cakes and chocolate.

How do you treat COVID fatigue? ›

Therapies, like meditation, gentle massage, deep breathing, or relaxation therapy, might be helpful. Important note: Patients should talk with their doctors about all potential therapies because many treatments that are promoted as cures for CFS are unproven, often costly, and could be dangerous.